tm logo

Monitor this mark

View On USPTO

Z
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 17 Feb 2021

Last Applicant/ Owned by

Zynerba Pharmaceuticals, Inc.

80 W. Lancaster Avenue

Devon

PA

19333

Serial Number

86398253 filed on 18th Sep 2014

Registration Number

4847465 registered on 03rd Nov 2015

in the Principal Register

Correspondent Address

Sarah Anne Keefe

Sarah Anne Keefe

Two International Place, Suite 2310

Boston MA 02110

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

Z

Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development

First Use Date in General

31st Jul 2015

First Use Date in Commerce

31st Jul 2015

Mark Details

Serial Number

No 86398253

Mark Type

No Service Mark

Attorney Docket Number

No ZYN 0004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.03 -

Incomplete circles (more than semi-circles)

Legal History

Show more

Status DateAction Taken
17th Feb 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
17th Feb 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
16th Feb 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04th Nov 2020TEAS SECTION 8 & 15 RECEIVED
03rd Nov 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14th Feb 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
06th Dec 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06th Dec 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03rd Nov 2015REGISTERED-PRINCIPAL REGISTER
30th Sep 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED